Global Expectorant Drug Market Growth 2024-2030

List of Tables

    Table 1. Expectorant Drug Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)

    Table 2. Expectorant Drug Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)

    Table 3. Major Players of Oral Solid

    Table 4. Major Players of Oral Liquid

    Table 5. Major Players of Inhalants

    Table 6. Global Expectorant Drug Sales by Type (2019-2024) & (K Units)

    Table 7. Global Expectorant Drug Sales Market Share by Type (2019-2024)

    Table 8. Global Expectorant Drug Revenue by Type (2019-2024) & ($ million)

    Table 9. Global Expectorant Drug Revenue Market Share by Type (2019-2024)

    Table 10. Global Expectorant Drug Sale Price by Type (2019-2024) & (US$/Unit)

    Table 11. Global Expectorant Drug Sales by Application (2019-2024) & (K Units)

    Table 12. Global Expectorant Drug Sales Market Share by Application (2019-2024)

    Table 13. Global Expectorant Drug Revenue by Application (2019-2024)

    Table 14. Global Expectorant Drug Revenue Market Share by Application (2019-2024)

    Table 15. Global Expectorant Drug Sale Price by Application (2019-2024) & (US$/Unit)

    Table 16. Global Expectorant Drug Sales by Company (2019-2024) & (K Units)

    Table 17. Global Expectorant Drug Sales Market Share by Company (2019-2024)

    Table 18. Global Expectorant Drug Revenue by Company (2019-2024) ($ Millions)

    Table 19. Global Expectorant Drug Revenue Market Share by Company (2019-2024)

    Table 20. Global Expectorant Drug Sale Price by Company (2019-2024) & (US$/Unit)

    Table 21. Key Manufacturers Expectorant Drug Producing Area Distribution and Sales Area

    Table 22. Players Expectorant Drug Products Offered

    Table 23. Expectorant Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)

    Table 24. New Products and Potential Entrants

    Table 25. Mergers & Acquisitions, Expansion

    Table 26. Global Expectorant Drug Sales by Geographic Region (2019-2024) & (K Units)

    Table 27. Global Expectorant Drug Sales Market Share Geographic Region (2019-2024)

    Table 28. Global Expectorant Drug Revenue by Geographic Region (2019-2024) & ($ millions)

    Table 29. Global Expectorant Drug Revenue Market Share by Geographic Region (2019-2024)

    Table 30. Global Expectorant Drug Sales by Country/Region (2019-2024) & (K Units)

    Table 31. Global Expectorant Drug Sales Market Share by Country/Region (2019-2024)

    Table 32. Global Expectorant Drug Revenue by Country/Region (2019-2024) & ($ millions)

    Table 33. Global Expectorant Drug Revenue Market Share by Country/Region (2019-2024)

    Table 34. Americas Expectorant Drug Sales by Country (2019-2024) & (K Units)

    Table 35. Americas Expectorant Drug Sales Market Share by Country (2019-2024)

    Table 36. Americas Expectorant Drug Revenue by Country (2019-2024) & ($ Millions)

    Table 37. Americas Expectorant Drug Revenue Market Share by Country (2019-2024)

    Table 38. Americas Expectorant Drug Sales by Type (2019-2024) & (K Units)

    Table 39. Americas Expectorant Drug Sales by Application (2019-2024) & (K Units)

    Table 40. APAC Expectorant Drug Sales by Region (2019-2024) & (K Units)

    Table 41. APAC Expectorant Drug Sales Market Share by Region (2019-2024)

    Table 42. APAC Expectorant Drug Revenue by Region (2019-2024) & ($ Millions)

    Table 43. APAC Expectorant Drug Revenue Market Share by Region (2019-2024)

    Table 44. APAC Expectorant Drug Sales by Type (2019-2024) & (K Units)

    Table 45. APAC Expectorant Drug Sales by Application (2019-2024) & (K Units)

    Table 46. Europe Expectorant Drug Sales by Country (2019-2024) & (K Units)

    Table 47. Europe Expectorant Drug Sales Market Share by Country (2019-2024)

    Table 48. Europe Expectorant Drug Revenue by Country (2019-2024) & ($ Millions)

    Table 49. Europe Expectorant Drug Revenue Market Share by Country (2019-2024)

    Table 50. Europe Expectorant Drug Sales by Type (2019-2024) & (K Units)

    Table 51. Europe Expectorant Drug Sales by Application (2019-2024) & (K Units)

    Table 52. Middle East & Africa Expectorant Drug Sales by Country (2019-2024) & (K Units)

    Table 53. Middle East & Africa Expectorant Drug Sales Market Share by Country (2019-2024)

    Table 54. Middle East & Africa Expectorant Drug Revenue by Country (2019-2024) & ($ Millions)

    Table 55. Middle East & Africa Expectorant Drug Revenue Market Share by Country (2019-2024)

    Table 56. Middle East & Africa Expectorant Drug Sales by Type (2019-2024) & (K Units)

    Table 57. Middle East & Africa Expectorant Drug Sales by Application (2019-2024) & (K Units)

    Table 58. Key Market Drivers & Growth Opportunities of Expectorant Drug

    Table 59. Key Market Challenges & Risks of Expectorant Drug

    Table 60. Key Industry Trends of Expectorant Drug

    Table 61. Expectorant Drug Raw Material

    Table 62. Key Suppliers of Raw Materials

    Table 63. Expectorant Drug Distributors List

    Table 64. Expectorant Drug Customer List

    Table 65. Global Expectorant Drug Sales Forecast by Region (2025-2030) & (K Units)

    Table 66. Global Expectorant Drug Revenue Forecast by Region (2025-2030) & ($ millions)

    Table 67. Americas Expectorant Drug Sales Forecast by Country (2025-2030) & (K Units)

    Table 68. Americas Expectorant Drug Revenue Forecast by Country (2025-2030) & ($ millions)

    Table 69. APAC Expectorant Drug Sales Forecast by Region (2025-2030) & (K Units)

    Table 70. APAC Expectorant Drug Revenue Forecast by Region (2025-2030) & ($ millions)

    Table 71. Europe Expectorant Drug Sales Forecast by Country (2025-2030) & (K Units)

    Table 72. Europe Expectorant Drug Revenue Forecast by Country (2025-2030) & ($ millions)

    Table 73. Middle East & Africa Expectorant Drug Sales Forecast by Country (2025-2030) & (K Units)

    Table 74. Middle East & Africa Expectorant Drug Revenue Forecast by Country (2025-2030) & ($ millions)

    Table 75. Global Expectorant Drug Sales Forecast by Type (2025-2030) & (K Units)

    Table 76. Global Expectorant Drug Revenue Forecast by Type (2025-2030) & ($ Millions)

    Table 77. Global Expectorant Drug Sales Forecast by Application (2025-2030) & (K Units)

    Table 78. Global Expectorant Drug Revenue Forecast by Application (2025-2030) & ($ Millions)

    Table 79. Abbott Laboratories Basic Information, Expectorant Drug Manufacturing Base, Sales Area and Its Competitors

    Table 80. Abbott Laboratories Expectorant Drug Product Portfolios and Specifications

    Table 81. Abbott Laboratories Expectorant Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 82. Abbott Laboratories Main Business

    Table 83. Abbott Laboratories Latest Developments

    Table 84. Acella Pharmaceuticals LLC Basic Information, Expectorant Drug Manufacturing Base, Sales Area and Its Competitors

    Table 85. Acella Pharmaceuticals LLC Expectorant Drug Product Portfolios and Specifications

    Table 86. Acella Pharmaceuticals LLC Expectorant Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 87. Acella Pharmaceuticals LLC Main Business

    Table 88. Acella Pharmaceuticals LLC Latest Developments

    Table 89. Astrazeneca Plc. Basic Information, Expectorant Drug Manufacturing Base, Sales Area and Its Competitors

    Table 90. Astrazeneca Plc. Expectorant Drug Product Portfolios and Specifications

    Table 91. Astrazeneca Plc. Expectorant Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 92. Astrazeneca Plc. Main Business

    Table 93. Astrazeneca Plc. Latest Developments

    Table 94. Cipla Limited Basic Information, Expectorant Drug Manufacturing Base, Sales Area and Its Competitors

    Table 95. Cipla Limited Expectorant Drug Product Portfolios and Specifications

    Table 96. Cipla Limited Expectorant Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 97. Cipla Limited Main Business

    Table 98. Cipla Limited Latest Developments

    Table 99. Dabur India Ltd Basic Information, Expectorant Drug Manufacturing Base, Sales Area and Its Competitors

    Table 100. Dabur India Ltd Expectorant Drug Product Portfolios and Specifications

    Table 101. Dabur India Ltd Expectorant Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 102. Dabur India Ltd Main Business

    Table 103. Dabur India Ltd Latest Developments

    Table 104. Glenmark Pharmaceuticals Limited Basic Information, Expectorant Drug Manufacturing Base, Sales Area and Its Competitors

    Table 105. Glenmark Pharmaceuticals Limited Expectorant Drug Product Portfolios and Specifications

    Table 106. Glenmark Pharmaceuticals Limited Expectorant Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 107. Glenmark Pharmaceuticals Limited Main Business

    Table 108. Glenmark Pharmaceuticals Limited Latest Developments

    Table 109. lohnson and Johnson Basic Information, Expectorant Drug Manufacturing Base, Sales Area and Its Competitors

    Table 110. lohnson and Johnson Expectorant Drug Product Portfolios and Specifications

    Table 111. lohnson and Johnson Expectorant Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 112. lohnson and Johnson Main Business

    Table 113. lohnson and Johnson Latest Developments

    Table 114. Merck KGaA Basic Information, Expectorant Drug Manufacturing Base, Sales Area and Its Competitors

    Table 115. Merck KGaA Expectorant Drug Product Portfolios and Specifications

    Table 116. Merck KGaA Expectorant Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 117. Merck KGaA Main Business

    Table 118. Merck KGaA Latest Developments

    Table 119. Novartis International AG Basic Information, Expectorant Drug Manufacturing Base, Sales Area and Its Competitors

    Table 120. Novartis International AG Expectorant Drug Product Portfolios and Specifications

    Table 121. Novartis International AG Expectorant Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 122. Novartis International AG Main Business

    Table 123. Novartis International AG Latest Developments

    Table 124. Pfizer Inc. Basic Information, Expectorant Drug Manufacturing Base, Sales Area and Its Competitors

    Table 125. Pfizer Inc. Expectorant Drug Product Portfolios and Specifications

    Table 126. Pfizer Inc. Expectorant Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 127. Pfizer Inc. Main Business

    Table 128. Pfizer Inc. Latest Developments

    Table 129. Proctor and Gamble Co Basic Information, Expectorant Drug Manufacturing Base, Sales Area and Its Competitors

    Table 130. Proctor and Gamble Co Expectorant Drug Product Portfolios and Specifications

    Table 131. Proctor and Gamble Co Expectorant Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 132. Proctor and Gamble Co Main Business

    Table 133. Proctor and Gamble Co Latest Developments

    Table 134. Reckitt Benckiser Group plc Basic Information, Expectorant Drug Manufacturing Base, Sales Area and Its Competitors

    Table 135. Reckitt Benckiser Group plc Expectorant Drug Product Portfolios and Specifications

    Table 136. Reckitt Benckiser Group plc Expectorant Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 137. Reckitt Benckiser Group plc Main Business

    Table 138. Reckitt Benckiser Group plc Latest Developments

    Table 139. Sanofi SA Basic Information, Expectorant Drug Manufacturing Base, Sales Area and Its Competitors

    Table 140. Sanofi SA Expectorant Drug Product Portfolios and Specifications

    Table 141. Sanofi SA Expectorant Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 142. Sanofi SA Main Business

    Table 143. Sanofi SA Latest Developments

    Table 144. The Himalaya Drug Company Basic Information, Expectorant Drug Manufacturing Base, Sales Area and Its Competitors

    Table 145. The Himalaya Drug Company Expectorant Drug Product Portfolios and Specifications

    Table 146. The Himalaya Drug Company Expectorant Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 147. The Himalaya Drug Company Main Business

    Table 148. The Himalaya Drug Company Latest Developments

    Table 149. Perrigo Company plc Basic Information, Expectorant Drug Manufacturing Base, Sales Area and Its Competitors

    Table 150. Perrigo Company plc Expectorant Drug Product Portfolios and Specifications

    Table 151. Perrigo Company plc Expectorant Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 152. Perrigo Company plc Main Business

    Table 153. Perrigo Company plc Latest Developments

    Table 154. Vernalis plc Basic Information, Expectorant Drug Manufacturing Base, Sales Area and Its Competitors

    Table 155. Vernalis plc Expectorant Drug Product Portfolios and Specifications

    Table 156. Vernalis plc Expectorant Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 157. Vernalis plc Main Business

    Table 158. Vernalis plc Latest Developments

    Table 159. Tris Pharma Inc. Basic Information, Expectorant Drug Manufacturing Base, Sales Area and Its Competitors

    Table 160. Tris Pharma Inc. Expectorant Drug Product Portfolios and Specifications

    Table 161. Tris Pharma Inc. Expectorant Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 162. Tris Pharma Inc. Main Business

    Table 163. Tris Pharma Inc. Latest Developments

    Table 164. Aytu BioScience Inc. Basic Information, Expectorant Drug Manufacturing Base, Sales Area and Its Competitors

    Table 165. Aytu BioScience Inc. Expectorant Drug Product Portfolios and Specifications

    Table 166. Aytu BioScience Inc. Expectorant Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 167. Aytu BioScience Inc. Main Business

    Table 168. Aytu BioScience Inc. Latest Developments

    Table 169. Mayne Pharma Inc. Basic Information, Expectorant Drug Manufacturing Base, Sales Area and Its Competitors

    Table 170. Mayne Pharma Inc. Expectorant Drug Product Portfolios and Specifications

    Table 171. Mayne Pharma Inc. Expectorant Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 172. Mayne Pharma Inc. Main Business

    Table 173. Mayne Pharma Inc. Latest Developments

    Table 174. Taro Pharmaceutical Industries Ltd. Basic Information, Expectorant Drug Manufacturing Base, Sales Area and Its Competitors

    Table 175. Taro Pharmaceutical Industries Ltd. Expectorant Drug Product Portfolios and Specifications

    Table 176. Taro Pharmaceutical Industries Ltd. Expectorant Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 177. Taro Pharmaceutical Industries Ltd. Main Business

    Table 178. Taro Pharmaceutical Industries Ltd. Latest Developments

    Table 179. Amneal Pharmaceuticals LLC Basic Information, Expectorant Drug Manufacturing Base, Sales Area and Its Competitors

    Table 180. Amneal Pharmaceuticals LLC Expectorant Drug Product Portfolios and Specifications

    Table 181. Amneal Pharmaceuticals LLC Expectorant Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 182. Amneal Pharmaceuticals LLC Main Business

    Table 183. Amneal Pharmaceuticals LLC Latest Developments

    Table 184. Aurobindo Pharma Ltd Basic Information, Expectorant Drug Manufacturing Base, Sales Area and Its Competitors

    Table 185. Aurobindo Pharma Ltd Expectorant Drug Product Portfolios and Specifications

    Table 186. Aurobindo Pharma Ltd Expectorant Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 187. Aurobindo Pharma Ltd Main Business

    Table 188. Aurobindo Pharma Ltd Latest Developments

    Table 189. GlaxoSmithKline plc. Basic Information, Expectorant Drug Manufacturing Base, Sales Area and Its Competitors

    Table 190. GlaxoSmithKline plc. Expectorant Drug Product Portfolios and Specifications

    Table 191. GlaxoSmithKline plc. Expectorant Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 192. GlaxoSmithKline plc. Main Business

    Table 193. GlaxoSmithKline plc. Latest Developments

List of Figures

    Figure 1. Picture of Expectorant Drug

    Figure 2. Expectorant Drug Report Years Considered

    Figure 3. Research Objectives

    Figure 4. Research Methodology

    Figure 5. Research Process and Data Source

    Figure 6. Global Expectorant Drug Sales Growth Rate 2019-2030 (K Units)

    Figure 7. Global Expectorant Drug Revenue Growth Rate 2019-2030 ($ Millions)

    Figure 8. Expectorant Drug Sales by Region (2019, 2023 & 2030) & ($ Millions)

    Figure 9. Product Picture of Oral Solid

    Figure 10. Product Picture of Oral Liquid

    Figure 11. Product Picture of Inhalants

    Figure 12. Global Expectorant Drug Sales Market Share by Type in 2023

    Figure 13. Global Expectorant Drug Revenue Market Share by Type (2019-2024)

    Figure 14. Expectorant Drug Consumed in Hospital

    Figure 15. Global Expectorant Drug Market: Hospital (2019-2024) & (K Units)

    Figure 16. Expectorant Drug Consumed in Clinic

    Figure 17. Global Expectorant Drug Market: Clinic (2019-2024) & (K Units)

    Figure 18. Expectorant Drug Consumed in Other

    Figure 19. Global Expectorant Drug Market: Other (2019-2024) & (K Units)

    Figure 20. Global Expectorant Drug Sales Market Share by Application (2023)

    Figure 21. Global Expectorant Drug Revenue Market Share by Application in 2023

    Figure 22. Expectorant Drug Sales Market by Company in 2023 (K Units)

    Figure 23. Global Expectorant Drug Sales Market Share by Company in 2023

    Figure 24. Expectorant Drug Revenue Market by Company in 2023 ($ Million)

    Figure 25. Global Expectorant Drug Revenue Market Share by Company in 2023

    Figure 26. Global Expectorant Drug Sales Market Share by Geographic Region (2019-2024)

    Figure 27. Global Expectorant Drug Revenue Market Share by Geographic Region in 2023

    Figure 28. Americas Expectorant Drug Sales 2019-2024 (K Units)

    Figure 29. Americas Expectorant Drug Revenue 2019-2024 ($ Millions)

    Figure 30. APAC Expectorant Drug Sales 2019-2024 (K Units)

    Figure 31. APAC Expectorant Drug Revenue 2019-2024 ($ Millions)

    Figure 32. Europe Expectorant Drug Sales 2019-2024 (K Units)

    Figure 33. Europe Expectorant Drug Revenue 2019-2024 ($ Millions)

    Figure 34. Middle East & Africa Expectorant Drug Sales 2019-2024 (K Units)

    Figure 35. Middle East & Africa Expectorant Drug Revenue 2019-2024 ($ Millions)

    Figure 36. Americas Expectorant Drug Sales Market Share by Country in 2023

    Figure 37. Americas Expectorant Drug Revenue Market Share by Country in 2023

    Figure 38. Americas Expectorant Drug Sales Market Share by Type (2019-2024)

    Figure 39. Americas Expectorant Drug Sales Market Share by Application (2019-2024)

    Figure 40. United States Expectorant Drug Revenue Growth 2019-2024 ($ Millions)

    Figure 41. Canada Expectorant Drug Revenue Growth 2019-2024 ($ Millions)

    Figure 42. Mexico Expectorant Drug Revenue Growth 2019-2024 ($ Millions)

    Figure 43. Brazil Expectorant Drug Revenue Growth 2019-2024 ($ Millions)

    Figure 44. APAC Expectorant Drug Sales Market Share by Region in 2023

    Figure 45. APAC Expectorant Drug Revenue Market Share by Regions in 2023

    Figure 46. APAC Expectorant Drug Sales Market Share by Type (2019-2024)

    Figure 47. APAC Expectorant Drug Sales Market Share by Application (2019-2024)

    Figure 48. China Expectorant Drug Revenue Growth 2019-2024 ($ Millions)

    Figure 49. Japan Expectorant Drug Revenue Growth 2019-2024 ($ Millions)

    Figure 50. South Korea Expectorant Drug Revenue Growth 2019-2024 ($ Millions)

    Figure 51. Southeast Asia Expectorant Drug Revenue Growth 2019-2024 ($ Millions)

    Figure 52. India Expectorant Drug Revenue Growth 2019-2024 ($ Millions)

    Figure 53. Australia Expectorant Drug Revenue Growth 2019-2024 ($ Millions)

    Figure 54. China Taiwan Expectorant Drug Revenue Growth 2019-2024 ($ Millions)

    Figure 55. Europe Expectorant Drug Sales Market Share by Country in 2023

    Figure 56. Europe Expectorant Drug Revenue Market Share by Country in 2023

    Figure 57. Europe Expectorant Drug Sales Market Share by Type (2019-2024)

    Figure 58. Europe Expectorant Drug Sales Market Share by Application (2019-2024)

    Figure 59. Germany Expectorant Drug Revenue Growth 2019-2024 ($ Millions)

    Figure 60. France Expectorant Drug Revenue Growth 2019-2024 ($ Millions)

    Figure 61. UK Expectorant Drug Revenue Growth 2019-2024 ($ Millions)

    Figure 62. Italy Expectorant Drug Revenue Growth 2019-2024 ($ Millions)

    Figure 63. Russia Expectorant Drug Revenue Growth 2019-2024 ($ Millions)

    Figure 64. Middle East & Africa Expectorant Drug Sales Market Share by Country in 2023

    Figure 65. Middle East & Africa Expectorant Drug Revenue Market Share by Country in 2023

    Figure 66. Middle East & Africa Expectorant Drug Sales Market Share by Type (2019-2024)

    Figure 67. Middle East & Africa Expectorant Drug Sales Market Share by Application (2019-2024)

    Figure 68. Egypt Expectorant Drug Revenue Growth 2019-2024 ($ Millions)

    Figure 69. South Africa Expectorant Drug Revenue Growth 2019-2024 ($ Millions)

    Figure 70. Israel Expectorant Drug Revenue Growth 2019-2024 ($ Millions)

    Figure 71. Turkey Expectorant Drug Revenue Growth 2019-2024 ($ Millions)

    Figure 72. GCC Country Expectorant Drug Revenue Growth 2019-2024 ($ Millions)

    Figure 73. Manufacturing Cost Structure Analysis of Expectorant Drug in 2023

    Figure 74. Manufacturing Process Analysis of Expectorant Drug

    Figure 75. Industry Chain Structure of Expectorant Drug

    Figure 76. Channels of Distribution

    Figure 77. Global Expectorant Drug Sales Market Forecast by Region (2025-2030)

    Figure 78. Global Expectorant Drug Revenue Market Share Forecast by Region (2025-2030)

    Figure 79. Global Expectorant Drug Sales Market Share Forecast by Type (2025-2030)

    Figure 80. Global Expectorant Drug Revenue Market Share Forecast by Type (2025-2030)

    Figure 81. Global Expectorant Drug Sales Market Share Forecast by Application (2025-2030)

    Figure 82. Global Expectorant Drug Revenue Market Share Forecast by Application (2025-2030)